RxDoctor Payments DataLook up a doctor →

ARCALYST: payments to doctors

Payments that named ARCALYST as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$2.7M
Providers
15,866
Transactions
44,028
Average per transaction
$62

The per-transaction average — $62 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 15,866 providers the average total is $171, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Kiniksa Pharmaceuticals International, PLC$1,650,27360.8%
Kiniksa Pharmaceuticals, Ltd.$1,063,58739.2%
← All drugs & devices